Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Gorman

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Nature Medicine|June 15, 2021
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trialAditi R Saxena, Donal N Gorman, Ryan M Esquejo, et al.
BMJ (Clinical Research Ed.)|August 11, 2000
A taxonomy of generic clinical questions: classification studyJ W Ely, J A Osheroff, P N Gorman, et al.
Infection Control and Hospital Epidemiology|March 2, 2018
Empiric Antibiotic Prescribing Decisions Among Medical Residents: The Role of the AntibiogramGregory B Tallman, Rowena A Vilches-Tran, Miriam R Elman, et al.
The Biochemical Journal|April 16, 1998
Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant miceP R Sinclair, N Gorman, T Dalton, et al.
Archives of Biochemistry and Biophysics|January 1, 1993
In vivo fate of hemopexin and heme-hemopexin complexes in the ratD Potter, Z C Chroneos, J W Baynes, et al.
Toxicology and Applied Pharmacology|January 13, 2000
CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and ironP R Sinclair, N Gorman, H S Walton, et al.
Journal of the American Medical Informatics Association : JAMIA|October 28, 2008
Tiering drug-drug interaction alerts by severity increases compliance ratesMarilyn D Paterno, Saverio M Maviglia, Paul N Gorman, et al.
The Biochemical Journal|July 15, 1988
Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acidA J Urquhart, G H Elder, A G Roberts, et al.
Diagnostic Microbiology and Infectious Disease|April 2, 2013
Comparison of antibiograms developed for inpatients and primary care outpatientsJessina C McGregor, David T Bearden, John M Townes, et al.
Diabetes, Obesity & Metabolism|June 20, 2025
Efficacy and safety of danuglipron (PF-06882961) in adults with obesity: A randomized, placebo-controlled, dose-ranging phase 2b studyClare Buckeridge, Sonia Cobain, Harold E Bays, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Nature Medicine|June 15, 2021
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trialAditi R Saxena, Donal N Gorman, Ryan M Esquejo, et al.
BMJ (Clinical Research Ed.)|August 11, 2000
A taxonomy of generic clinical questions: classification studyJ W Ely, J A Osheroff, P N Gorman, et al.
Infection Control and Hospital Epidemiology|March 2, 2018
Empiric Antibiotic Prescribing Decisions Among Medical Residents: The Role of the AntibiogramGregory B Tallman, Rowena A Vilches-Tran, Miriam R Elman, et al.
The Biochemical Journal|April 16, 1998
Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant miceP R Sinclair, N Gorman, T Dalton, et al.
Archives of Biochemistry and Biophysics|January 1, 1993
In vivo fate of hemopexin and heme-hemopexin complexes in the ratD Potter, Z C Chroneos, J W Baynes, et al.
Toxicology and Applied Pharmacology|January 13, 2000
CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and ironP R Sinclair, N Gorman, H S Walton, et al.
Journal of the American Medical Informatics Association : JAMIA|October 28, 2008
Tiering drug-drug interaction alerts by severity increases compliance ratesMarilyn D Paterno, Saverio M Maviglia, Paul N Gorman, et al.
The Biochemical Journal|July 15, 1988
Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acidA J Urquhart, G H Elder, A G Roberts, et al.
Diagnostic Microbiology and Infectious Disease|April 2, 2013
Comparison of antibiograms developed for inpatients and primary care outpatientsJessina C McGregor, David T Bearden, John M Townes, et al.
Diabetes, Obesity & Metabolism|June 20, 2025
Efficacy and safety of danuglipron (PF-06882961) in adults with obesity: A randomized, placebo-controlled, dose-ranging phase 2b studyClare Buckeridge, Sonia Cobain, Harold E Bays, et al.
Pageof 11